These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8149117)

  • 1. Impaired in vivo immune responses in patients with melancholia.
    Hickie I; Hickie C; Lloyd A; Silove D; Wakefield D
    Br J Psychiatry; 1993 May; 162():651-7. PubMed ID: 8149117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression.
    Maes M; Mihaylova I; Kubera M; Ringel K
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):169-75. PubMed ID: 21945535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorders.
    Anesi A; Franciotta D; Di Paolo E; Zardini E; Melzi d'Eril GV; Zerbi F
    Funct Neurol; 1994; 9(1):17-22. PubMed ID: 8082849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function in depression: a distinct pattern of frontal impairment in melancholia?
    Austin MP; Mitchell P; Wilhelm K; Parker G; Hickie I; Brodaty H; Chan J; Eyers K; Milic M; Hadzi-Pavlovic D
    Psychol Med; 1999 Jan; 29(1):73-85. PubMed ID: 10077295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing melancholic depression: some personal observations.
    Parker G
    Australas Psychiatry; 2017 Feb; 25(1):21-24. PubMed ID: 27422742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression.
    Lloyd A; Hickie I; Hickie C; Dwyer J; Wakefield D
    Clin Exp Immunol; 1992 Jan; 87(1):76-9. PubMed ID: 1733640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential impact of age on the phenomenology of melancholia.
    Parker G; Roy K; Hadzi-Pavlovic D; Wilhelm K; Mitchell P
    Psychol Med; 2001 Oct; 31(7):1231-6. PubMed ID: 11681549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression.
    Wodarz N; Rupprecht R; Kornhuber J; Schmitz B; Wild K; Braner HU; Riederer P
    J Affect Disord; 1991 Aug; 22(4):241-8. PubMed ID: 1658104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression.
    Maes M; Ringel K; Kubera M; Berk M; Rybakowski J
    J Affect Disord; 2012 Feb; 136(3):386-92. PubMed ID: 22166399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of psychotic symptoms in those with melancholic and nonmelancholic depression.
    Caldieraro MA; Baeza FL; Pinheiro DO; Ribeiro MR; Parker G; Fleck MP
    J Nerv Ment Dis; 2013 Oct; 201(10):855-9. PubMed ID: 24080672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression: a preliminary report.
    Hickie I; Hickie C; Bennett B; Wakefield D; Silove D; Mitchell P; Lloyd A
    Int J Immunopharmacol; 1995 Aug; 17(8):685-90. PubMed ID: 8847163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying and differentiating melancholic depression in a non-clinical sample.
    Parker G; Tavella G; Hadzi-Pavlovic D
    J Affect Disord; 2019 Jan; 243():194-200. PubMed ID: 30245251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminating melancholic and non-melancholic depression by prototypic clinical features.
    Parker G; McCraw S; Blanch B; Hadzi-Pavlovic D; Synnott H; Rees AM
    J Affect Disord; 2013 Jan; 144(3):199-207. PubMed ID: 22868058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining age effects on prototypic melancholic symptoms as a strategy for refining definition of melancholia.
    Hyett MP; Parker GB; Proudfoot J; Fletcher K
    J Affect Disord; 2008 Jul; 109(1-2):193-7. PubMed ID: 18162189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a new prototypic measure of melancholia.
    Parker G; McCraw S; Fletcher K; Friend P; Futeran S
    Compr Psychiatry; 2013 Oct; 54(7):835-41. PubMed ID: 23602392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring melancholia: the utility of a prototypic symptom approach.
    Parker G; Fletcher K; Hyett M; Hadzi-Pavlovic D; Barrett M; Synnott H
    Psychol Med; 2009 Jun; 39(6):989-98. PubMed ID: 18796174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interdependence of subtype and severity: contributions of clinical and neuropsychological features to melancholia and non-melancholia in an outpatient sample.
    Quinn C; Harris A; Kemp A
    J Int Neuropsychol Soc; 2012 Mar; 18(2):361-9. PubMed ID: 22300644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melancholic/endogenous depression and response to somatic treatment and placebo.
    Peselow ED; Sanfilipo MP; Difiglia C; Fieve RR
    Am J Psychiatry; 1992 Oct; 149(10):1324-34. PubMed ID: 1388334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different immune patterns in melancholic and non-melancholic major depression.
    Rothermundt M; Arolt V; Fenker J; Gutbrodt H; Peters M; Kirchner H
    Eur Arch Psychiatry Clin Neurosci; 2001; 251(2):90-7. PubMed ID: 11407444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory markers in major depression and melancholia.
    Rothermundt M; Arolt V; Peters M; Gutbrodt H; Fenker J; Kersting A; Kirchner H
    J Affect Disord; 2001 Mar; 63(1-3):93-102. PubMed ID: 11246085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.